Report Overview
Report Summary
The global Swine Influenza Vaccines market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Swine Influenza Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Swine Influenza Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Swine Influenza Vaccines in these regions.
This research report categorizes the global Swine Influenza Vaccines market by top players/brands, region, type and end user. This report also studies the global Swine Influenza Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Chengdu TECBOND
Green Cross Veterinary
Hipra
MSD Animal Health (Merck)
Zoetis
CAHIC
Merial
Ceva
Ringpu Biology
DHN
Market size by Product
Live Vaccines
Killed Vaccines
Market size by End User
Commodity Pig
Breeding Pig
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Swine Influenza Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Swine Influenza Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Swine Influenza Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Swine Influenza Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Swine Influenza Vaccines are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Swine Influenza Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Swine Influenza Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Swine Influenza Vaccines Market Size Growth Rate by Product
1.4.2 Live Vaccines
1.4.3 Killed Vaccines
1.5 Market by End User
1.5.1 Global Swine Influenza Vaccines Market Size Growth Rate by End User
1.5.2 Commodity Pig
1.5.3 Breeding Pig
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Swine Influenza Vaccines Market Size
2.1.1 Global Swine Influenza Vaccines Revenue 2017-2027
2.1.2 Global Swine Influenza Vaccines Sales 2017-2027
2.2 Swine Influenza Vaccines Growth Rate by Regions
2.2.1 Global Swine Influenza Vaccines Sales by Regions
2.2.2 Global Swine Influenza Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Swine Influenza Vaccines Sales by Manufacturers
3.1.1 Swine Influenza Vaccines Sales by Manufacturers
3.1.2 Swine Influenza Vaccines Sales Market Share by Manufacturers
3.1.3 Global Swine Influenza Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Swine Influenza Vaccines Revenue by Manufacturers
3.2.1 Swine Influenza Vaccines Revenue by Manufacturers (2017-2020)
3.2.2 Swine Influenza Vaccines Revenue Share by Manufacturers (2017-2020)
3.3 Swine Influenza Vaccines Price by Manufacturers
3.4 Swine Influenza Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Swine Influenza Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Swine Influenza Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Swine Influenza Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Swine Influenza Vaccines Sales by Product
4.2 Global Swine Influenza Vaccines Revenue by Product
4.3 Swine Influenza Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Swine Influenza Vaccines Breakdown Data by End User
6 North America
6.1 North America Swine Influenza Vaccines by Countries
6.1.1 North America Swine Influenza Vaccines Sales by Countries
6.1.2 North America Swine Influenza Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Swine Influenza Vaccines by Product
6.3 North America Swine Influenza Vaccines by End User
7 Europe
7.1 Europe Swine Influenza Vaccines by Countries
7.1.1 Europe Swine Influenza Vaccines Sales by Countries
7.1.2 Europe Swine Influenza Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Swine Influenza Vaccines by Product
7.3 Europe Swine Influenza Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Swine Influenza Vaccines by Countries
8.1.1 Asia Pacific Swine Influenza Vaccines Sales by Countries
8.1.2 Asia Pacific Swine Influenza Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Swine Influenza Vaccines by Product
8.3 Asia Pacific Swine Influenza Vaccines by End User
9 Central & South America
9.1 Central & South America Swine Influenza Vaccines by Countries
9.1.1 Central & South America Swine Influenza Vaccines Sales by Countries
9.1.2 Central & South America Swine Influenza Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Swine Influenza Vaccines by Product
9.3 Central & South America Swine Influenza Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Swine Influenza Vaccines by Countries
10.1.1 Middle East and Africa Swine Influenza Vaccines Sales by Countries
10.1.2 Middle East and Africa Swine Influenza Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Swine Influenza Vaccines by Product
10.3 Middle East and Africa Swine Influenza Vaccines by End User
11 Company Profiles
11.1 Chengdu TECBOND
11.1.1 Chengdu TECBOND Company Details
11.1.2 Company Business Overview
11.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Chengdu TECBOND Swine Influenza Vaccines Products Offered
11.1.5 Chengdu TECBOND Recent Development
11.2 Green Cross Veterinary
11.2.1 Green Cross Veterinary Company Details
11.2.2 Company Business Overview
11.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Green Cross Veterinary Swine Influenza Vaccines Products Offered
11.2.5 Green Cross Veterinary Recent Development
11.3 Hipra
11.3.1 Hipra Company Details
11.3.2 Company Business Overview
11.3.3 Hipra Swine Influenza Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Hipra Swine Influenza Vaccines Products Offered
11.3.5 Hipra Recent Development
11.4 MSD Animal Health (Merck)
11.4.1 MSD Animal Health (Merck) Company Details
11.4.2 Company Business Overview
11.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.4.4 MSD Animal Health (Merck) Swine Influenza Vaccines Products Offered
11.4.5 MSD Animal Health (Merck) Recent Development
11.5 Zoetis
11.5.1 Zoetis Company Details
11.5.2 Company Business Overview
11.5.3 Zoetis Swine Influenza Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Zoetis Swine Influenza Vaccines Products Offered
11.5.5 Zoetis Recent Development
11.6 CAHIC
11.6.1 CAHIC Company Details
11.6.2 Company Business Overview
11.6.3 CAHIC Swine Influenza Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.6.4 CAHIC Swine Influenza Vaccines Products Offered
11.6.5 CAHIC Recent Development
11.7 Merial
11.7.1 Merial Company Details
11.7.2 Company Business Overview
11.7.3 Merial Swine Influenza Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Merial Swine Influenza Vaccines Products Offered
11.7.5 Merial Recent Development
11.8 Ceva
11.8.1 Ceva Company Details
11.8.2 Company Business Overview
11.8.3 Ceva Swine Influenza Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Ceva Swine Influenza Vaccines Products Offered
11.8.5 Ceva Recent Development
11.9 Ringpu Biology
11.9.1 Ringpu Biology Company Details
11.9.2 Company Business Overview
11.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Ringpu Biology Swine Influenza Vaccines Products Offered
11.9.5 Ringpu Biology Recent Development
11.10 DHN
11.10.1 DHN Company Details
11.10.2 Company Business Overview
11.10.3 DHN Swine Influenza Vaccines Sales, Revenue and Gross Margin (2017-2020)
11.10.4 DHN Swine Influenza Vaccines Products Offered
11.10.5 DHN Recent Development
12 Future Forecast
12.1 Swine Influenza Vaccines Market Forecast by Regions
12.1.1 Global Swine Influenza Vaccines Sales Forecast by Regions 2021-2027
12.1.2 Global Swine Influenza Vaccines Revenue Forecast by Regions 2021-2027
12.2 Swine Influenza Vaccines Market Forecast by Product
12.2.1 Global Swine Influenza Vaccines Sales Forecast by Product 2021-2027
12.2.2 Global Swine Influenza Vaccines Revenue Forecast by Product 2021-2027
12.3 Swine Influenza Vaccines Market Forecast by End User
12.4 North America Swine Influenza Vaccines Forecast
12.5 Europe Swine Influenza Vaccines Forecast
12.6 Asia Pacific Swine Influenza Vaccines Forecast
12.7 Central & South America Swine Influenza Vaccines Forecast
12.8 Middle East and Africa Swine Influenza Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Swine Influenza Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer